Yokoyama A - Search Results

1

MLL becomes functional through intra-molecular interaction not by proteolytic processing.

Yokoyama A, Ficara F, Murphy MJ, Meisel C, Hatanaka C, Kitabayashi I, Cleary ML. Yokoyama A, et al. PLoS One. 2013 Sep 10;8(9):e73649. doi: 10.1371/journal.pone.0073649. eCollection 2013. PLoS One. 2013. PMID: 24040009 Free PMC article.

2

The AML1-MTG8 leukemic fusion protein forms a complex with a novel member of the MTG8(ETO/CDR) family, MTGR1.

Kitabayashi I, Ida K, Morohoshi F, Yokoyama A, Mitsuhashi N, Shimizu K, Nomura N, Hayashi Y, Ohki M. Kitabayashi I, et al. Among authors: yokoyama a. Mol Cell Biol. 1998 Feb;18(2):846-58. doi: 10.1128/MCB.18.2.846. Mol Cell Biol. 1998. PMID: 9447981 Free PMC article.

3

Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation.

Kitabayashi I, Yokoyama A, Shimizu K, Ohki M. Kitabayashi I, et al. Among authors: yokoyama a. EMBO J. 1998 Jun 1;17(11):2994-3004. doi: 10.1093/emboj/17.11.2994. EMBO J. 1998. PMID: 9606182 Free PMC article.

4

The conserved domain CR2 of Epstein-Barr virus nuclear antigen leader protein is responsible not only for nuclear matrix association but also for nuclear localization.

Yokoyama A, Kawaguchi Y, Kitabayashi I, Ohki M, Hirai K. Yokoyama A, et al. Virology. 2001 Jan 20;279(2):401-13. doi: 10.1006/viro.2000.0715. Virology. 2001. PMID: 11162796 Free article.

5

Fusion of MOZ and p300 histone acetyltransferases in acute monocytic leukemia with a t(8;22)(p11;q13) chromosome translocation.

Kitabayashi I, Aikawa Y, Yokoyama A, Hosoda F, Nagai M, Kakazu N, Abe T, Ohki M. Kitabayashi I, et al. Among authors: yokoyama a. Leukemia. 2001 Jan;15(1):89-94. doi: 10.1038/sj.leu.2401983. Leukemia. 2001. PMID: 11243405

6

Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein.

Kitabayashi I, Aikawa Y, Nguyen LA, Yokoyama A, Ohki M. Kitabayashi I, et al. Among authors: yokoyama a. EMBO J. 2001 Dec 17;20(24):7184-96. doi: 10.1093/emboj/20.24.7184. EMBO J. 2001. PMID: 11742995 Free PMC article.

7

Leukemia proto-oncoprotein MLL is proteolytically processed into 2 fragments with opposite transcriptional properties.

Yokoyama A, Kitabayashi I, Ayton PM, Cleary ML, Ohki M. Yokoyama A, et al. Blood. 2002 Nov 15;100(10):3710-8. doi: 10.1182/blood-2002-04-1015. Epub 2002 Jun 28. Blood. 2002. PMID: 12393701 Free article.

8

Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression.

Yokoyama A, Wang Z, Wysocka J, Sanyal M, Aufiero DJ, Kitabayashi I, Herr W, Cleary ML. Yokoyama A, et al. Mol Cell Biol. 2004 Jul;24(13):5639-49. doi: 10.1128/MCB.24.13.5639-5649.2004. Mol Cell Biol. 2004. PMID: 15199122 Free PMC article.

9

The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis.

Yokoyama A, Somervaille TC, Smith KS, Rozenblatt-Rosen O, Meyerson M, Cleary ML. Yokoyama A, et al. Cell. 2005 Oct 21;123(2):207-18. doi: 10.1016/j.cell.2005.09.025. Cell. 2005. PMID: 16239140 Free article.

10

Menin critically links MLL proteins with LEDGF on cancer-associated target genes.

Yokoyama A, Cleary ML. Yokoyama A, et al. Cancer Cell. 2008 Jul 8;14(1):36-46. doi: 10.1016/j.ccr.2008.05.003. Cancer Cell. 2008. PMID: 18598942 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,498 results

Search Page

Filters